當前位置：BPS Bioscience Inc.>>CAR T-Cell Therapy Cell Lines>> 79557CD22 CHO Recombinant Cell Line (Medium and High Expression)
Anti-BCMA CAR /NFAT (Luciferase) Re
Anti-CD19 CAR / NFAT (Luciferase) R
Recombinant clonal stable CHO cell line constitutively expressing full length human CD22 protein (Genbank #NM_001771). Surface expression of CD22 was confirmed by flow cytometry. This clonal cell line was selected for medium level expression of CD22. Please contact BPS Bioscience for additional information.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供，信息內容的真實性、準確性和合法性由相關企業(yè)負責，化工儀器網對此不承擔任何保證責任。
溫馨提示：為規(guī)避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
化工儀器網